Spencer Ryan
Insider CIK 1777938 · DVAX Co-President and Senior VP, Director · CDTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 400,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 130,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 250,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 350,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 280,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 231,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 225,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 55,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 90,667 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 50,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | U Tender | 2026-02-10 | 2026-02-10 | 379,620 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 165,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2026-02-10 | 2026-02-10 | 136,000 | — | $0 | 136,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 136,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2026-02-10 | 2026-02-10 | 165,000 | — | $0 | 165,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 4,250 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-12-24 | 2025-12-29 | 138,168 | $15.38 | $2.13M | 379,620 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-12-23 | 2025-12-29 | 45,333 | — | $0 | 90,667 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-12-23 | 2025-12-29 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-12-23 | 2025-12-29 | 45,333 | — | $0 | 517,788 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-12-23 | 2025-12-29 | 55,000 | — | $0 | 472,455 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2025-12-23 | 2025-12-29 | 156,250 | — | $0 | 417,455 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-02-18 | 2025-02-20 | 55,000 | — | $0 | 110,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-02-18 | 2025-02-20 | 36,528 | $12.93 | $472.3K | 260,733 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-02-18 | 2025-02-20 | 55,000 | — | $0 | 297,261 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-13 | 2025-02-18 | 62,500 | — | $0 | 62,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-02-13 | 2025-02-18 | 62,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-13 | 2025-02-18 | 225,000 | — | $0 | 225,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-13 | 2025-02-18 | 136,000 | — | $0 | 136,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-02-13 | 2025-02-18 | 62,500 | — | $0 | 273,522 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-02-13 | 2025-02-18 | 31,694 | $12.69 | $402.2K | 242,261 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-02-10 | 2025-02-12 | 20,833 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-02-10 | 2025-02-12 | 11,209 | $13.20 | $148.0K | 211,022 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-02-10 | 2025-02-12 | 20,833 | — | $0 | 222,231 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-04-26 | 2024-04-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-02-15 | 2024-02-20 | 231,000 | — | $0 | 231,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-02-15 | 2024-02-20 | 165,000 | — | $0 | 165,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2024-02-15 | 2024-02-20 | 402 | $9.45 | $3.8K | 201,030 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2024-02-12 | 2024-02-13 | 11,684 | $12.82 | $149.8K | 200,628 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2024-02-10 | 2024-02-13 | 20,833 | — | $0 | 20,833 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2024-02-10 | 2024-02-13 | 20,833 | — | $0 | 212,312 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2024-02-05 | 2024-02-06 | 17,129 | $12.79 | $219.1K | 191,479 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2024-02-04 | 2024-02-06 | 29,750 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2024-02-04 | 2024-02-06 | 29,750 | — | $0 | 208,608 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2023-02-27 | 2023-03-01 | 29,750 | — | $0 | 29,750 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2023-02-27 | 2023-03-01 | 20,834 | — | $0 | 41,666 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2023-02-27 | 2023-03-01 | 14,673 | $10.36 | $152.0K | 178,459 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2023-02-27 | 2023-03-01 | 20,834 | — | $0 | 174,019 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2023-02-27 | 2023-03-01 | 9,888 | — | $0 | 157,855 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2023-02-27 | 2023-03-01 | 4,670 | $10.36 | $48.4K | 153,185 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2023-02-27 | 2023-03-01 | 10,637 | $10.36 | $110.2K | 163,382 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2023-02-27 | 2023-03-01 | 29,750 | — | $0 | 193,132 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2023-02-16 | 2023-02-21 | 280,000 | — | $0 | 280,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2023-02-15 | 2023-02-21 | 1,786 | $9.73 | $17.4K | 147,967 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-12-09 | 2022-12-13 | 9,888 | — | $0 | 9,888 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2022-08-15 | 2023-02-21 | 1,668 | $10.29 | $17.2K | 146,181 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2022-08-09 | 2022-08-10 | 14,921 | $16.92 | $252.5K | 144,513 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2022-08-08 | 2022-08-10 | 29,663 | — | $0 | 9,887 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2022-08-08 | 2022-08-10 | 29,663 | — | $0 | 159,434 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2022-03-03 | 2022-03-04 | 12,662 | $10.57 | $133.8K | 170,467 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2022-03-03 | 2022-03-04 | 17,611 | $10.57 | $186.1K | 182,606 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | S Sale | 2022-03-03 | 2022-03-04 | 52,835 | $10.56 | $557.9K | 129,771 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2022-03-02 | 2022-03-04 | 29,750 | — | $0 | 59,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2022-03-02 | 2022-03-04 | 20,833 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2022-03-02 | 2022-03-04 | 20,833 | — | $0 | 183,129 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2022-03-02 | 2022-03-04 | 29,750 | — | $0 | 200,217 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2022-02-15 | 2022-03-04 | 1,457 | $10.29 | $15.0K | 162,296 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-02-10 | 2022-02-14 | 350,000 | — | $0 | 350,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-02-10 | 2022-02-14 | 62,500 | — | $0 | 62,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2022-02-10 | 2022-02-14 | 89,250 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2022-02-10 | 2022-02-14 | 89,250 | — | $0 | 160,839 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2021-08-13 | 2022-02-14 | 1,969 | $3.39 | $6.7K | 71,589 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2021-02-22 | 2021-02-23 | 20,833 | — | $0 | 20,833 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2021-02-22 | 2021-02-23 | 10,791 | $9.60 | $103.6K | 69,620 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2021-02-22 | 2021-02-23 | 1,519 | $3.39 | $5.1K | 59,578 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2021-02-22 | 2021-02-23 | 20,833 | — | $0 | 80,411 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-02-04 | 2021-02-05 | 89,250 | — | $0 | 89,250 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-02-04 | 2021-02-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2020-08-14 | 2021-02-05 | 1,518 | $3.39 | $5.1K | 58,059 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2020-02-22 | 2020-02-25 | 20,834 | — | $0 | 41,666 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2020-02-22 | 2020-02-25 | 6,375 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2020-02-22 | 2020-02-25 | 6,375 | — | $0 | 35,707 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2020-02-22 | 2020-02-25 | 20,834 | — | $0 | 56,541 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2020-02-13 | 2020-02-14 | 130,000 | — | $0 | 130,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2020-02-05 | 2020-02-14 | 1,562 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2020-02-05 | 2020-02-14 | 1,562 | — | $0 | 28,117 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2019-12-16 | 2019-12-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2019-06-14 | 2019-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2019-06-02 | 2019-06-04 | 4,875 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2019-06-02 | 2019-06-04 | 4,875 | — | $0 | 25,582 | SEC↗ |